Hi, mooers!
TSLA is releasing its Q4 2024 earnings on January 29 after the bell. Unlock insights with TSLA Earnings Hub>>
Don't want to miss first-hand information? Subscribe to @Moo Live and book the earnings conference live stream NOW!
For the details of indicator sentiment, please tap the link and check.
Since its Q3 2024 earnings release, shares of $Tesla (TSLA.US)$ have a increase of 99.47%. How will the market react to the...

$Citius Pharmaceuticals (CTXR.US)$ With a full warehouse, you can only watch as the price of this cabbage is bought up.

$NVIDIA (NVDA.US)$ Managed to sell 2 at 130. Will be selling more as Mpox has arrived in Southeast Asia.
Hope Teledoc will rise up like it's glorious days

$Citius Pharmaceuticals (CTXR.US)$ Can any expert analyze it?
1. The financial report is out - interpret it as neither good nor bad.
2. The subsidiary has merged - interpret it as good news.
3. FDA has also approved - interpreted as good news.
In this situation, why did the stock fall like this? Where is the logic?
1. Is the FDA warning label on the box because it didn't meet expectations?
2. Have all bullish news been exhausted, but the stock price hasn't risen much?
3. Is the institution lurking for new news on the 13th to intentionally suppress the stock price and prepare to push the price up?
4. Are all funds preparing to go to CCTOR instead?

$Citius Pharmaceuticals (CTXR.US)$
Today's trading volume increased

$BioNTech (BNTX.US)$ or $Novavax (NVAX.US)$